CompanyDrug

Innovent Biologics Initiates Phase III Neoshot Study for MSI-H/dMMR Colon Cancer Treatment

CompanyDrug

Alexion’s Ultomiris Secures FDA Approval for Anti-AQP4 Positive NMOSD Treatment

Policy / Regulatory

NMPA Mandates Electronic Permits for Anesthetic Drugs and Psychotropic Substances

Company

Shanghai Fosun Pharma Reports 2023 Revenues, Highlights Innovation and R&D Progress

CompanyDeals

AbbVie Acquires Landos Biopharma to Boost Autoimmune Disease Pipeline

Policy / Regulatory

National Drug Sampling Inspection Report Reveals High Compliance Rates in 2023

CompanyDrug

MSD’s Winrevair Approved by FDA as First Activin Signaling Inhibitor for Pulmonary Arterial Hypertension

Policy / Regulatory

China’s National Adverse Drug Reaction Report for 2023 Highlights Stability in Reporting Trends

Company

Lee’s Pharmaceutical Holdings Ltd Reports 2023 Financials with Focus Shift to Patented and Generic Drugs

Company

Hansoh Pharmaceutical Group Reports 7.7% YOY Revenue Growth and Expands R&D Spending

CompanyDeals

Shanghai Pharmaceuticals, SHC, and CEMCS CAS Renew Partnership to Incubate Pharmaceutical Innovations

CompanyPolicy / Regulatory

Kobayashi Pharmaceutical Recalls Red Yeast Rice Pills in China Amid Health Concerns